Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.

Grajewski RS, Hansen AM, Agarwal RK, Kronenberg M, Sidobre S, Su SB, Silver PB, Tsuji M, Franck RW, Lawton AP, Chan CC, Caspi RR.

J Immunol. 2008 Oct 1;181(7):4791-7.

2.

CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.

Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, Garavaglia C, Borsellino G, Dellabona P, Bonneville M, Scotet E, Casorati G.

Blood. 2007 Jul 1;110(1):251-8. Epub 2007 Mar 15.

3.

Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation.

Giabbai B, Sidobre S, Crispin MD, Sanchez-Ruìz Y, Bachi A, Kronenberg M, Wilson IA, Degano M.

J Immunol. 2005 Jul 15;175(2):977-84.

4.

Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.

Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, Sidobre S, Kronenberg M, Hogaboam CM, Swain MG.

J Immunol. 2005 Jun 15;174(12):8027-37.

5.

Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids.

Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, Dustin ML, Littman DR.

PLoS Biol. 2005 Apr;3(4):e113. Epub 2005 Apr 5.

6.

Cutting edge: IFN-gamma signaling to macrophages is required for optimal Valpha14i NK T/NK cell cross-talk.

Wesley JD, Robbins SH, Sidobre S, Kronenberg M, Terrizzi S, Brossay L.

J Immunol. 2005 Apr 1;174(7):3864-8.

7.

Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice.

Zaccone P, Raine T, Sidobre S, Kronenberg M, Mastroeni P, Cooke A.

Eur J Immunol. 2004 Nov;34(11):3246-56.

8.

The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition.

Sidobre S, Hammond KJ, Bénazet-Sidobre L, Maltsev SD, Richardson SK, Ndonye RM, Howell AR, Sakai T, Besra GS, Porcelli SA, Kronenberg M.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12254-9. Epub 2004 Aug 10.

9.

Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies.

Berzins SP, Kyparissoudis K, Pellicci DG, Hammond KJ, Sidobre S, Baxter A, Smyth MJ, Kronenberg M, Godfrey DI.

Immunol Cell Biol. 2004 Jun;82(3):247-52. Erratum in: Immunol Cell Biol. 2004 Jun;82(3):342.

PMID:
15186254
10.

In vivo activation of invariant V alpha 14 natural killer T cells by alpha-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity.

Lisbonne M, Hachem P, Tonanny MB, Fourneau JM, Sidobre S, Kronenberg M, Van Endert P, Dy M, Schneider E, Leite-de-Moraes MC.

Eur J Immunol. 2004 May;34(5):1381-8.

11.

CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1.

Huang MM, Borszcz P, Sidobre S, Kronenberg M, Kane KP.

J Immunol. 2004 May 1;172(9):5304-12.

12.

Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.

Stenström M, Sköld M, Ericsson A, Beaudoin L, Sidobre S, Kronenberg M, Lehuen A, Cardell S.

Eur J Immunol. 2004 Jan;34(1):56-65.

13.

Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity.

Campos RA, Szczepanik M, Itakura A, Akahira-Azuma M, Sidobre S, Kronenberg M, Askenase PW.

J Exp Med. 2003 Dec 15;198(12):1785-96.

14.

MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.

Sköld M, Stenström M, Sidobre S, Höglund P, Kronenberg M, Cardell S.

Immunology. 2003 Nov;110(3):313-21.

15.

Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.

Zeng D, Liu Y, Sidobre S, Kronenberg M, Strober S.

J Clin Invest. 2003 Oct;112(8):1211-22.

16.

Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells.

Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJ, Hayakawa Y, Sidobre S, Keating R, Kronenberg M, Smyth MJ, Godfrey DI.

J Immunol. 2003 Oct 15;171(8):4020-7.

17.

Genetic control of NKT cell numbers maps to major diabetes and lupus loci.

Esteban LM, Tsoutsman T, Jordan MA, Roach D, Poulton LD, Brooks A, Naidenko OV, Sidobre S, Godfrey DI, Baxter AG.

J Immunol. 2003 Sep 15;171(6):2873-8.

18.

An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.

Dieli F, Taniguchi M, Kronenberg M, Sidobre S, Ivanyi J, Fattorini L, Iona E, Orefici G, De Leo G, Russo D, Caccamo N, Sireci G, Di Sano C, Salerno A.

J Immunol. 2003 Aug 15;171(4):1961-8.

19.

Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.

Lisbonne M, Diem S, de Castro Keller A, Lefort J, Araujo LM, Hachem P, Fourneau JM, Sidobre S, Kronenberg M, Taniguchi M, Van Endert P, Dy M, Askenase P, Russo M, Vargaftig BB, Herbelin A, Leite-de-Moraes MC.

J Immunol. 2003 Aug 15;171(4):1637-41.

20.

Cross-presentation of disialoganglioside GD3 to natural killer T cells.

Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB.

J Exp Med. 2003 Jul 7;198(1):173-81.

21.

Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo.

Matsuda JL, Gapin L, Baron JL, Sidobre S, Stetson DB, Mohrs M, Locksley RM, Kronenberg M.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8395-400. Epub 2003 Jun 26.

22.

Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide.

Pellicci DG, Uldrich AP, Kyparissoudis K, Crowe NY, Brooks AG, Hammond KJ, Sidobre S, Kronenberg M, Smyth MJ, Godfrey DI.

Eur J Immunol. 2003 Jul;33(7):1816-23.

23.

NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells.

Elewaut D, Shaikh RB, Hammond KJ, De Winter H, Leishman AJ, Sidobre S, Turovskaya O, Prigozy TI, Ma L, Banks TA, Lo D, Ware CF, Cheroutre H, Kronenberg M.

J Exp Med. 2003 Jun 16;197(12):1623-33.

24.

Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes.

Zaccone P, Fehérvári Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, Cooke A.

Eur J Immunol. 2003 May;33(5):1439-49.

25.

Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics.

Sim BC, Holmberg K, Sidobre S, Naidenko O, Niederberger N, Marine SD, Kronenberg M, Gascoigne NR.

Immunogenetics. 2003 Mar;54(12):874-83. Epub 2003 Feb 14.

PMID:
12671739
26.

Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity.

Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, DeKruyff RH, Umetsu DT.

Nat Med. 2003 May;9(5):582-8. Epub 2003 Mar 31.

PMID:
12669034
27.

Homeostasis of V alpha 14i NKT cells.

Matsuda JL, Gapin L, Sidobre S, Kieper WC, Tan JT, Ceredig R, Surh CD, Kronenberg M.

Nat Immunol. 2002 Oct;3(10):966-74. Epub 2002 Sep 9.

PMID:
12244311
28.

CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells.

Sidobre S, Kronenberg M.

J Immunol Methods. 2002 Oct 1;268(1):107-21. Review.

PMID:
12213347
29.

The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.

Sidobre S, Naidenko OV, Sim BC, Gascoigne NR, Garcia KC, Kronenberg M.

J Immunol. 2002 Aug 1;169(3):1340-8.

32.

Adjuvant lipopeptide interaction with model membranes.

Gonzalez-Christen J, Vergne I, Süssmuth R, Sidobre S, Prats M, Tocanne JF, Lanéelle G.

Biochim Biophys Acta. 1998 Jan 5;1368(1):97-107.

33.

Expression and pharmacological characterization of the human mu-opioid receptor in the methylotrophic yeast Pichia pastoris.

Talmont F, Sidobre S, Demange P, Milon A, Emorine LJ.

FEBS Lett. 1996 Oct 7;394(3):268-72.

Supplemental Content

Loading ...
Support Center